5 announcements about to drop as per recent online company update available on the AVH website:
1. Proof of concept delivery of genetically modified cells - before end 2021 2. Proof of concept impact of telomerase in mouse model (anti aging application that is by no means certain but enormous market if it works) - before end 2021 3. Japan approval coming - either December or January 4. Outpatient C-Code/TPT outpatient burns Q1 2022 5. FDA approval new ease of use RECELL device (for vitiligo and outpatient burns) H1 2022
Also discussed by the CEO was the "enormous revenue" expected from vitiligo sales as the only curative treatment ever invented
Don't believe me watch the following recent recording for an update:
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)